OMC

OUP Management Company Portfolio holdings

AUM $44.5M
This Quarter Return
-31.4%
1 Year Return
+54.04%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$72.7M
AUM Growth
+$72.7M
Cap. Flow
-$6.19M
Cap. Flow %
-8.53%
Top 10 Hldgs %
94.86%
Holding
16
New
–
Increased
–
Reduced
3
Closed
1

Top Buys

No buys this quarter

Top Sells

1
IONQ icon
IonQ
IONQ
$4.13M
2
SERA icon
Sera Prognostics
SERA
$1.28M
3
EVLV icon
Evolv Technologies
EVLV
$633K
4
LABP
Landos Biopharma, Inc. Common Stock
LABP
$156K

Sector Composition

1 Healthcare 85.9%
2 Technology 8.3%
3 Industrials 5.79%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
$14.3M 19.69%
2,937,615
– –
PMVP icon
2
PMV Pharmaceuticals
PMVP
$74.2M
$14.1M 19.4%
989,232
– –
JBIO
3
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$9.44M 12.99%
603,762
– –
DICE
4
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$8.33M 11.46%
536,693
– –
CYT
5
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$7.4M 10.18%
2,474,572
– –
IONQ icon
6
IonQ
IONQ
$12.7B
$6.03M 8.3%
1,377,597
-941,922
-41% -$4.13M
EVLV icon
7
Evolv Technologies
EVLV
$1.42B
$4.21M 5.79%
1,582,721
-238,145
-13% -$633K
VOR icon
8
Vor Biopharma
VOR
$250M
$1.86M 2.56%
374,714
– –
DTIL icon
9
Precision BioSciences
DTIL
$57.8M
$1.8M 2.47%
1,123,913
– –
EFTR
10
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$1.46M 2%
1,025,697
– –
LABP
11
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$1.17M 1.62%
1,612,764
-214,714
-12% -$156K
RNAC icon
12
Cartesian Therapeutics
RNAC
$261M
$1.13M 1.56%
862,543
– –
LENZ
13
LENZ Therapeutics
LENZ
$1.1B
$1.12M 1.54%
406,308
– –
SPRO icon
14
Spero Therapeutics
SPRO
$116M
$185K 0.25%
249,070
– –
QTTB icon
15
Q32 Bio
QTTB
$20.9M
$126K 0.17%
64,000
– –
SERA icon
16
Sera Prognostics
SERA
$123M
– –
-337,505
Closed -$1.28M